AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Top Gum Industries Ltd.

Investor Presentation Aug 25, 2025

7093_rns_2025-08-25_639c665f-b71b-488c-acd3-094ffc9960ea.pdf

Investor Presentation

Open in Viewer

Opens in native device viewer

Q2 2025

August 26, 2025

The information included under this presentation (the "Presentation") is for informational purposes only and does not constitute or form any part of any offer to purchase securities and/or an invitation to make offers for their purchase or solicitation of any of the above regarding any securities of Top Gum Industries Ltd. (the "Company") and should not be regarded as a recommendation or an opinion. Any such offer or sale will be made on the basis of a prospectus published by the Company after receiving a permit from the Securities Authority and approval from the Tel Aviv Stock Exchange (hereinafter, respectively: "Securities Authority" and "the Stock Exchange").

This presentation does not purport to encompass or contain any information that may be relevant for the purpose of making any decision regarding an investment in the Company's securities and generally. This presentation does not replace independent data collection and analysis, it should be bear in mind that past data does not necessarily indicate future performance. The presentation includes data and statistics and other publications published by third parties, the content of which has not been independently verified by the Company. The presentation was made, for a convenient and concise presentation, and it does not exhaust the full data about the company and its activities and does

not replace the need to perform a full due diligence. The information contained in this presentation is incomplete and all that is stated in it is subject to a full due diligence and is not a substitute for reviewing reports published by the Company to the public and especially in the draft prospectus or final company prospectus, supplementary prospectus and shelf prospectus. The information under this Presentation is not a substitute for public Information and in the event of any conflict between the content of this presentation and the content of any public Information, the content of the Public Information shall prevail. The information in this Presentation should not be relied upon as any representation or warranty, express or implied, of the Company. No reliance should be made on the fairness, accuracy, completeness or correctness of the information or opinions contained herein. No legally binding obligations may be created, implied, or inferred from this Presentation. Various statements in this presentation include information which derives from forecasts, estimates, assessments, and other information pertaining to future events and/or matters, the materialization of which is uncertain and beyond the Company's control, and which constitute "forwardlooking information", as defined under the Israeli Securities Law, 1968. Forward-looking statements include descriptions regarding the intent,

belief, or current expectations of the Company and are not guaranteeing future results, performance, or achievements and are based on current expectations, estimations, and assumptions, involve certain risks and uncertainties which are difficult to predict and are not guarantees of future performance. Therefore, actual future results, performances, or achievements of the Company may differ materially from what is or may be expressed or implied in this presentation due to a variety of factors, many of which are beyond the Company's control, including, without limitation, certain risk factors. The Company does not undertake any obligation to update or revise any of the forward-looking statements, whether as a result of new information, future events, or otherwise. Certain information and factual statements (including relating to markets or trends) contained herein are based on or derived from publicly available documents or independent third-party sources, and therefore the accuracy of such information and the assumptions on which such information is based has not been independently verified. Nothing in this presentation constitutes tax or business advice and does not constitute a substitute consulting appropriate advisors in these aspects. Every potential investor should seek advice and guidance in connection with potential investments, including tax advice is given such investor tax status.

Q2 2025 HIGHLIGHTS

Best Ever Supplements Q2 USD 17.8M; 79% of Total Sales; +69% QoQ

All-Time Revenue Record USD 22.6M; +51% QoQ

Institutional Investors Stock Option Exercise ~USD 6.8M

Adjusted EBITDA USD 3.5M; +35% QoQ

Capital Raising ~ USD 28M (ILS 100M)

Customers' Orders Backlog for 30.6.25 including TopGum Canada

STRATEGIC PIVOTS

INNOVATIVE DELIVERY SYSTEM

Highest standards of nutraceuticals in the industry

Differentiated Matrix

GUMMICEUTICALS™ Truly sugar-free/No-added sugar | Prebiotic effect Organic (fiber or sugar based) | Unique fibers matrix

High Dosage

Highest dosage per one gummy without affecting the flavor Awarded winning products

Improved Functionality

Organoleptic Experience

Flavor | Color | Texture | Odor | Shape

High-resistance melting point

Clean label ingredients

Micro-encapsulation Masks flavors | Slow-release | Improves stability | Targeted release Enables new active ingredients | Preserves potency

NEW FACILITY IN FINAL STAGES

  • •••

USD thousands

22
573
,
14
992
,
7
581
,
15
603
,
9
615
,
5
988
,
6
970
,
5
377
,
1
593
,
9%
30
9%
35
0%
-5
1
214
,
760 454
2
035
,
1
100
,
935
2
138
,
1
887
,
251
1
727
,
0 1
727
,
144
-
1
630
,
1
774
-
,
6%
0
-
9%
10
5%
11
-
4
110
-
,
122 4
232
-
,
3
966
,
1
508
,
2
458
,
921 265 656
3
045
,
1
243
,
1
802
,
2
965
,
2
216
,
749
3
509
,
2
596
,
913
5%
15
3%
17
8%
1
-

18

SOLID FINANCIAL STRENGTH

USD thousands

30.06.2025 30.06.2024
Assets
Currents assets 58,210 49,230
Non-current assets 104,974 62,077
Total assets 163,184 111,307
Liabilities
Current liabilities 51,951 18.827
Non-current liabilities 33,122 23,946
Total liabilities 85,073 42,773
Equity
Share capital 3,170 3.071
Share premium 64,114 56,797
Capital reserves 4.706 -2,218
Retained earnings 6.121 10,884
Total equity 78,111 68,534
Total liabilities and equity 163.184 111,307

Thank you

Talk to a Data Expert

Have a question? We'll get back to you promptly.